According to this guy -
- With the CYP450 enzyme system, things first become hydroxylated, and then eliminated by one of several processes, which includes, if it's an amine compound, Oxidative Deamination... Ring a bell? So to me it appears that DMT should first rely on CYP2D6 to be inhibited, rather than MAO, so that it survives unscathed, and maybe after that, MAO-A inhibition could be important. But if CYP2D6 isn't inhibited, then the DMT get's metabolized by CYP2D6 and then is eliminated/excreted.
I think this ^ is what is orally activating DMT, not MAO-A inhibition, this makes too much sense to me right now, for it to be MAO-A inhibition. This basically means that if CYP2D6 isn't inhibited, DMT gets hydroxylated to 6-HO-DMT which so far as i know is inactive, and is then eliminated by Oxidative Deamination which, if i'm not mistaken DMT is said to be metabolized by MAO into Indole-3-acetic acid, which is a carboxylic acid which is part of what they call Oxoacids, which comes from the Oxidative Deamination process, which apparently only happens after DMT metabolizes into 6-HO-DMT by CYP2D6, not by MAO. And if this is indeed the case, then that means DMT's oral activation lies within the inhibition of CYP2D6, not MAO. And if that's the case, that would explain why other natural MAO-A inhibitors haven't worked for people trying to orally activate DMT.
Edit: From this page - https://mycotopia.net/forums/botanicals/63929-dmt-monoamine-oxidase-inhibitor-maoi-more.html - i found this quote "The relevance of hydroxylation as a metabolic pathway of DMT has received no further attention in the most recent studies and 6-hydroxy derivatives have not been assessed in several experiments on the in vivo and in vitro metabolism of DMT and 5-methoxy-DMT (Sitaram and McLeod, 1990)."
And this "In conclusion, all these studies point out that although oxidative deamination of the side chain by monoamine oxidase appears to be the main metabolic pathway of DMT, the drug can also be degraded by other routes, mainly N-oxidation, but possibly also by N-demethylation, 6-hydroxylation and cyclization. The extent to which these pathways may be active or even predominate when the drug is administered orally concomitantly with selective MAO inhibitors, as is the case in ayahuasca potions, remains to be assessed."
Also from this page - Synthesis of Deuterated N,N-Dimethyltryptamine (DMT) and 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) - "The dominance of the deamination pathway makes it difficult to study the minor metabolites. Traditionally this difficulty has been surmounted by pre-treating animals with an MAO inhibitor such as pargyline. Inhibition of the major catabolic route leads to "shunting" to the minor metabolic routes, facilitating the study of the minor metabolites. Unfortunately pre-treatment of animals with pargyline can give experimental results which are difficult to interpret since pargyline also inhibits the N-oxidation and demethylation of DMT by 90%." CYP2D6 mediates O-Demethylation as well as Hydroxylation, and both CYP2D6 and CYP3A4 apparently mediates N-Demethylation.
I think this ^ is what is orally activating DMT, not MAO-A inhibition, this makes too much sense to me right now, for it to be MAO-A inhibition. This basically means that if CYP2D6 isn't inhibited, DMT gets hydroxylated to 6-HO-DMT which so far as i know is inactive, and is then eliminated by Oxidative Deamination which, if i'm not mistaken DMT is said to be metabolized by MAO into Indole-3-acetic acid, which is a carboxylic acid which is part of what they call Oxoacids, which comes from the Oxidative Deamination process, which apparently only happens after DMT metabolizes into 6-HO-DMT by CYP2D6, not by MAO. And if this is indeed the case, then that means DMT's oral activation lies within the inhibition of CYP2D6, not MAO. And if that's the case, that would explain why other natural MAO-A inhibitors haven't worked for people trying to orally activate DMT.
Edit: From this page - https://mycotopia.net/forums/botanicals/63929-dmt-monoamine-oxidase-inhibitor-maoi-more.html - i found this quote "The relevance of hydroxylation as a metabolic pathway of DMT has received no further attention in the most recent studies and 6-hydroxy derivatives have not been assessed in several experiments on the in vivo and in vitro metabolism of DMT and 5-methoxy-DMT (Sitaram and McLeod, 1990)."
And this "In conclusion, all these studies point out that although oxidative deamination of the side chain by monoamine oxidase appears to be the main metabolic pathway of DMT, the drug can also be degraded by other routes, mainly N-oxidation, but possibly also by N-demethylation, 6-hydroxylation and cyclization. The extent to which these pathways may be active or even predominate when the drug is administered orally concomitantly with selective MAO inhibitors, as is the case in ayahuasca potions, remains to be assessed."
Also from this page - Synthesis of Deuterated N,N-Dimethyltryptamine (DMT) and 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) - "The dominance of the deamination pathway makes it difficult to study the minor metabolites. Traditionally this difficulty has been surmounted by pre-treating animals with an MAO inhibitor such as pargyline. Inhibition of the major catabolic route leads to "shunting" to the minor metabolic routes, facilitating the study of the minor metabolites. Unfortunately pre-treatment of animals with pargyline can give experimental results which are difficult to interpret since pargyline also inhibits the N-oxidation and demethylation of DMT by 90%." CYP2D6 mediates O-Demethylation as well as Hydroxylation, and both CYP2D6 and CYP3A4 apparently mediates N-Demethylation.
Oxidative deamination is, by definition, deamination (removal of amines), not dehydroxylation (removal of hydroxyl groups)